Italia markets closed


IOB - IOB Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
82,59-1,09 (-1,30%)
Alla chiusura: 06:00PM BST
Schermo intero
Chiusura precedente83,68
Denaro76,14 x 0
Lettera84,14 x 0
Min-Max giorno82,50 - 83,78
Intervallo di 52 settimane66,64 - 116,00
Media Volume135.028
Beta (5 anni mensile)0,32
Rapporto PE (ttm)38,96
EPS (ttm)2,12
Prossima data utiliN/D
Rendimento e dividendo (forward)1,33 (1,59%)
Data ex dividendo28 apr 2023
Stima target 1AN/D
  • GlobeNewswire

    UCB Convening Notice to the General Meeting of theShareholders 2023

    CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders for the general meeting of shareholders (the “General Meeting”) which will be held on Thursday, 27 April 2023, at 11:00 am CEST, at the registered office of UCB SA/NV, Allée de la Recherche 60 - 1070 Brussels, for the purpose of considering and voting on the items shown on the agenda set out below. Applicable participation formalities are detailed at the end of this convening notice. Sharehold

  • GlobeNewswire

    Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

    BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical company, today announced a strategic collaboration, based upon Praxis’ PRAX-020 program, for the discovery of small molecule therapeutics as potential treatments of KCNT1 related epilepsies. “We are excited to partner with UCB, a global leader in epilepsy drug development, as we work together toward a n